← All trials
NCT02128633
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2009
- Primary completion
- Jun 1, 2013
- Completion date
- Mar 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 126
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Universidade Federal de Santa MariaLead sponsor
- Universidade Federal de Santa MariaReponsible party - principal investigator
- Universidade Federal de Santa MariaStudy director
- Universidade Federal de Santa MariaStudy chair
- Franciscan University CenterCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.